Spinal Cord Stimulation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Spinal Cord Stimulation Market
The Spinal Cord Stimulation Market size was valued at USD 2.88 billion in 2019 and USD 2.41 billion in 2020 and is projected to grow USD 4.12 billion by 2027, exhibiting a CAGR of 8.0% during the forecast period of 2024-2032.
The COVID-19 pandemic substantially disrupted the spinal cord stimulation (SCS) market. Supply chain interruptions and decreased affected person visits to healthcare facilities in addition impacted market boom. However, as healthcare structures adjusted to the brand new everyday, the marketplace started out out getting better, supported thru increasing focus about persistent pain control and advancements in telehealth consultations. The pandemic additionally emphasised the significance of some distance off programming and comply with-up technologies for spinal wire stimulators, pushing the organization closer to innovation in non-touch affected person care solutions
One of the today's trends inside the SCS market is the improvement of customized stimulation technologies. Manufacturers are that specialize in developing gadgets that adapt to individual patient needs the use of artificial intelligence and superior algorithms. These systems permit real-time adjustment of stimulation parameters based totally on affected person interest and pain levels, enhancing healing results. Additionally, rechargeable and minimally invasive gadgets are gaining traction due to their convenience and decreased hazard of headaches. The integration of wearable era for far flung tracking and programming is in addition revolutionizing affected person care, permitting seamless interplay among patients and healthcare providers.
The growing occurrence of chronic pain conditions, which include neuropathic pain, failed back surgical operation syndrome (FBSS), and complicated regional pain syndrome (CRPS), is a chief using issue within the SCS market. As conventional pain control strategies, which includes opioids, face scrutiny because of addiction risks, spinal twine stimulators provide a safer and more effective opportunity. Rising attention among sufferers and healthcare companies about non-pharmacological answers has boosted call for for those gadgets. Additionally, advancements in device era, including improved battery life and wireless talents, are increasing adoption prices among patients and clinicians alike.
Comprehensive Analysis of Spinal Cord Stimulation Market
The Spinal Cord Stimulation Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated By product, by Disease, by end user. By Product include Rechargeable, Non-rechargeable. By Disease Indication include Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Others. By End User include Hospitals, Ambulatory Surgical Centers, Specialty Clinics.
The North America region lead the Spinal Cord Stimulation Market share by benefitting a market size of USD 2.13 billion Emerging government guidelines and favorable health reimbursement are the factors responsible for the expansion of the market in North America.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.
January 2020 – Medtronic p.C acquired Stimgenics LLC, a main agency that has pioneered a unique spinal twine stimulation waveform known as Differential Target Multiplexed SCS.
Segmentation Table
ATTRIBUTES DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD Billion)
Segmentation
By Product
Rechargeable
Non-rechargeable
By Disease Indication
Failed Back Surgery Syndrome (FBSS)
Degenerative Disc Disease (DDD)
Complex Regional Pain Syndrome (CRPS)
Arachnoiditis
Others
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Geography
North America
By Product
By Disease Indication
By End User
By Country
Europe
By Product
By Disease Indication
By End User
By Country/Sub-region
Asia Pacific
By Product
By Disease Indication
By End User
By Country/Sub-region
Rest of World
By Product
By Disease Indication
By End User
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Key Indications – For Key Countries/ Regions
- 4.2. Regulatory Scenario – For Key Countries/ Regions
- 4.3. Impact of COVID-19 on Global Spinal Cord Stimulation Market
- 4.4. New Product Launches
- 4.5. Key Industry Developments - Mergers, Acquisitions and Partnerships
- 5. Global Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Rechargeable
- 5.2.2. Non-rechargeable
- 5.3. Market Analysis, Insights and Forecast – By Disease Indication
- 5.3.1. Failed Back Surgery Syndrome (FBSS)
- 5.3.2. Degenerative Disc Disease (DDD)
- 5.3.3. Complex Regional Pain Syndrome (CRPS)
- 5.3.4. Arachnoiditis
- 5.3.5. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgery Centers
- 5.4.3. Specialty Clinics
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Rest of World
- 6. North America Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Rechargeable
- 6.2.2. Non-rechargeable
- 6.3. Market Analysis, Insights and Forecast – By Disease Indication
- 6.3.1. Failed Back Surgery Syndrome (FBSS)
- 6.3.2. Degenerative Disc Disease (DDD)
- 6.3.3. Complex Regional Pain Syndrome (CRPS)
- 6.3.4. Arachnoiditis
- 6.3.5. Others
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals
- 6.4.2. Ambulatory Surgery Centers
- 6.4.3. Specialty Clinics
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Rechargeable
- 7.2.2. Non-rechargeable
- 7.3. Market Analysis, Insights and Forecast – By Disease Indication
- 7.3.1. Failed Back Surgery Syndrome (FBSS)
- 7.3.2. Degenerative Disc Disease (DDD)
- 7.3.3. Complex Regional Pain Syndrome (CRPS)
- 7.3.4. Arachnoiditis
- 7.3.5. Others
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgery Centers
- 7.4.3. Specialty Clinics
- 7.5. Market Analysis, Insights and Forecast – By Countries/ Sub-regions
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Rechargeable
- 8.2.2. Non-rechargeable
- 8.3. Market Analysis, Insights and Forecast – By Disease Indication
- 8.3.1. Failed Back Surgery Syndrome (FBSS)
- 8.3.2. Degenerative Disc Disease (DDD)
- 8.3.3. Complex Regional Pain Syndrome (CRPS)
- 8.3.4. Arachnoiditis
- 8.3.5. Others
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgery Centers
- 8.4.3. Specialty Clinics
- 8.5. Market Analysis, Insights and Forecast – By Countries/ Sub-regions
- 8.5.1. India
- 8.5.2. Japan
- 8.5.3. China
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Rest of World Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Rechargeable
- 9.2.2. Non-rechargeable
- 9.3. Market Analysis, Insights and Forecast – By Disease Indication
- 9.3.1. Failed Back Surgery Syndrome (FBSS)
- 9.3.2. Degenerative Disc Disease (DDD)
- 9.3.3. Complex Regional Pain Syndrome (CRPS)
- 9.3.4. Arachnoiditis
- 9.3.5. Others
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals
- 9.4.2. Ambulatory Surgery Centers
- 9.4.3. Specialty Clinics
- 10. Competitive Analysis
- 10.1. Key Industry Developments
- 10.2. Global Market Share Analysis (2019)
- 10.3. Company Profiles (Overview, Product, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 10.3.1. Abbott
- 10.3.1.1. Overview
- 10.3.1.2. Product
- 10.3.1.3. SWOT analysis
- 10.3.1.4. Recent developments
- 10.3.1.5. strategies
- 10.3.1.6. financials (based on availability)
- 10.3.2. Boston Scientific Corporation
- 10.3.2.1. Overview
- 10.3.2.2. Product
- 10.3.2.3. SWOT analysis
- 10.3.2.4. Recent developments
- 10.3.2.5. strategies
- 10.3.2.6. financials (based on availability)
- 10.3.3. Stimwave LLC
- 10.3.3.1. Overview
- 10.3.3.2. Product
- 10.3.3.3. SWOT analysis
- 10.3.3.4. Recent developments
- 10.3.3.5. strategies
- 10.3.3.6. financials (based on availability)
- 10.3.4. Medtronic
- 10.3.4.1. Overview
- 10.3.4.2. Product
- 10.3.4.3. SWOT analysis
- 10.3.4.4. Recent developments
- 10.3.4.5. strategies
- 10.3.4.6. financials (based on availability)
- 10.3.5. Nevro Corp
- 10.3.5.1. Overview
- 10.3.5.2. Product
- 10.3.5.3. SWOT analysis
- 10.3.5.4. Recent developments
- 10.3.5.5. strategies
- 10.3.5.6. financials (based on availability)
- 10.3.6. Nuvectra
- 10.3.6.1. Overview
- 10.3.6.2. Product
- 10.3.6.3. SWOT analysis
- 10.3.6.4. Recent developments
- 10.3.6.5. strategies
- 10.3.6.6. financials (based on availability)
- 10.3.7. Other Prominent Players
- 10.3.7.1. Overview
- 10.3.7.2. Product
- 10.3.7.3. SWOT analysis
- 10.3.7.4. Recent developments
- 10.3.7.5. strategies
- 10.3.7.6. financials (based on availability)
- 11. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook